The HHS Secretary nominee has called for improvements in nutritional guidance and stricter criteria for American food. The Food and Drug Administration is moving to ban erythrosine, aka…
Read MoreCancer
Surgeon General Recommends Cancer Risk Warning on Alcohol Labels
He published a report linking seven cancer types to alcohol consumption. Surgeon General Vivek Murthy released a report recommending that alcohol labels should include cancer risk warnings. The…
Read MoreEPA Advances Risk Evaluations for Carcinogenic Chemicals
Five substances have been designated as high-priority for evaluation, with plans to review five additional chemicals. The U.S. Environmental Protection Agency (EPA) recently finalized the designation of five…
Read MoreSupreme Court Will Hear Case on Abortion Clinic Funding
South Carolina seeks to eliminate Medicaid from covering non-abortion Planned Parenthood services. The Supreme Court announced that it will hear arguments in Planned Parenthood’s lawsuit against the state…
Read MoreEPA Bans Cancer-Causing Dry Cleaning Chemicals, TCE, and PCE
Common ingredient causes liver, kidney, blood cancer, and nerve damage. The Environmental Protection Agency (EPA) has issued a final rule banning the use of cancer-causing chemicals in consumer…
Read MoreFDA Investigates “Forever Chemicals” in Seafood
Officials looking into the public health ramifications of PFAS contamination. The Food and Drug Administration (FDA) opened an investigation last month into the impact of per- and polyfluoroalkyl…
Read MoreHHS Adds 54 Drugs to Medicaid Drug Rebate Program
Drugs will have a lowered coinsurance rate for 822,000 enrollees. The Department of Health and Human Services (HHS) announced that 54 drugs have been added to Medicaid’s Drug…
Read MorePresident Announces $150 Million for “Cancer Moonshot“ Development
The funding will go toward removal technology with a goal of halving cancer deaths by 2047. President Joe Biden announced another $150 million investment into cancer treatment development,…
Read MoreFDA Approves First TCR Gene Therapy for Synovial Sarcoma
Tecelra treats rare cancer through immunotherapy. The U.S. Food and Drug Administration (FDA) has approved Tecelra (afamitresgene autoleucel), a gene therapy for adults with unresectable or metastatic synovial…
Read MoreEducation Department Releases Civil Rights Guides for Cancer Patients
The information added applies to students experiencing sickle cell disease and epilepsy. This month, the Department of Education released three new civil rights resources: one for students with…
Read More